STOCK COMPARISON

Abbott Laboratories vs Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret: Fair Value & Quality

Q: Is Abbott Laboratories or Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret more undervalued?

As of Sep 18, 2026, Abbott Laboratories is at -27% to fair value and Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret at -35%. Abbott Laboratories is the less overvalued of the two. Model-based estimate, not financial advice.

Q: Which has higher quality, Abbott Laboratories or Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret?

Abbott Laboratories has a quality score of 66/100 and Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret 33/100. Abbott Laboratories leads on quality.

Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) compare, as of Sep 18, 2026.

As of Sep 18, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $102 versus a fair value of $74.79 (-27%), while Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret trades at TRY 8.07 versus TRY 5.23 (-35%).

Abbott Laboratories

ABT · USD · Health Care

-27%

upside to fair value

overvalued

Price$102

Fair Value$74.79

Quality66/100

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

ANGEN.IS · TRY · Health Care

-35%

upside to fair value

overvalued

PriceTRY 8.07

Fair ValueTRY 5.23

Quality33/100

Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Abbott LaboratoriesAnatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

Valuation

27.7×P/E (TTM)—

3.89×P/S (TTM)0.05×

3.36×P/B—

15.1×EV/EBITDA2.6×

1.47×PEG—

−26.8%Fair value upside−35.2%

2.3%Dividend yield13.0%

$2.44Dividend per share—

Profitability

13%Operating margin3%

1.19×EBIT margin trend (5Y)—

12%Return on equity-16%

6%Return on assets-2%

Growth

8%Revenue growth (YoY)19%

0.5%Avg. growth/yr (3Y)40.1%

5.1%Avg. growth/yr (5Y)11.9%

+10.5%Value creation/yr—

Balance & size

23.6×Interest coverage (EBIT/interest)—

0.19×Debt / equity0.11×

$175BMarket cap$43M

healthyGrowth qualityexpensive

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret leads: 4 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Abbott Laboratoriesof which business quality 66 · market factors 49 Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaretof which business quality 33 · market factors 23

ProfitabilityMargins and returns on capital today

Quality GrowthAre margins and returns improving?

CashflowEarnings quality: real cash, not paper profit

Fin. StrengthBalance sheet, leverage, solvency risk

InvestmentDisciplined investing over empire-building

Low VolatilityCalm price path (market factor)

MomentumPrice trend over the last 3–12 months (market factor)

52W MomentumDistance to the 52-week high (market factor)

Net IssuanceShare count: buybacks or dilution?

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model family	Abbott LaboratoriesPrice $102	Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve TicaretPrice TRY 8.07
DCF Models	-29%below the price$73.01	n/a
Earnings-Based	-71%below the price$29.42	n/a
Dividend Discount	-61%below the price$39.73	n/a
Multiples	-31%below the price$70.72	-30%below the priceTRY 5.66
Asset-Based	-80%below the price$20.05	-34%below the priceTRY 5.29
Growth DCF	-34%below the price$67.02	n/a
Economic Profit	-63%below the price$37.49	n/a
Growth Earnings	-31%below the price$70.25	n/a
Minimum	-80%below the price$20.05	-34%below the priceTRY 5.29
Maximum	-29%below the price$73.01	-30%below the priceTRY 5.66
Median	-48%below the price$53.37	-32%below the priceTRY 5.48
Geometric mean	-55%below the price$46.36	-32%below the priceTRY 5.47

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret: 2 of 2 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Abbott Laboratories

Price $102

Fair Value $74.79

Bear $51.13Bull $94.43

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

Price TRY 8.07

Fair Value TRY 5.23

Bear TRY 3.73Bull TRY 6.74

Compare two other stocks

Tap a field and type again, ticker or company name.

First stock

Second stock

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Abbott Laboratories · Health Care

Quality score66 · Top 25%

Fair value upside-27% · below median

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret · Health Care

Quality score33 · bottom 25%

Fair value upside-35% · below median

Bottom line

Abbott Laboratories has the higher quality score (66/100).

See the full analysis →

Abbott Laboratories · Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Abbott Laboratories

Eli Lilly and vs UnitedHealth Group Microsoft vs Nvidia Apple vs Microsoft Microsoft vs Taiwan Semiconductor Manufacturing

Related to Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

Cisco Systems vs Nvidia Apple vs Cisco Systems Broadcom vs Microsoft Microsoft vs Micron Technology

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.